The Vitamin K2 and D3 Intervention Trial in Children and Adolescents With the Low-energy Fractures
Rationale and Design of the Vitamin K2 and Vitamin D3 Intervention Trial in Children and Adolescents With the Low-energy Bone Fractures
Sponsor: American Medical Holdings Inc
Listed as NCT03871322, this NA trial focuses on Deficiency of Vitamin K2 and Fracture Healing and remains ongoing. Sponsored by American Medical Holdings Inc, it has been updated 10 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Apr 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Apr 2021 — Apr 2023 [monthly]
Recruiting NA
-
Mar 2021 — Apr 2021 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Recruiting NA
-
Mar 2020 — Jan 2021 [monthly]
Recruiting NA
-
Nov 2019 — Mar 2020 [monthly]
Recruiting NA
-
Jul 2019 — Nov 2019 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Apr 2019 — Jul 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- American Medical Holdings Inc
- International Science & Health Foundation
- Lomza State University of Applied Sciences
- Medical University of Bialystok
For direct contact, visit the study record on ClinicalTrials.gov .